D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$501M |
| 2 |
Booking.com
BKNG
|
+$470M |
| 3 |
Qualcomm
QCOM
|
+$398M |
| 4 |
Chevron
CVX
|
+$268M |
| 5 |
Meta Platforms (Facebook)
META
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$914M |
| 2 |
Netflix
NFLX
|
+$305M |
| 3 |
Johnson & Johnson
JNJ
|
+$244M |
| 4 |
McDonald's
MCD
|
+$241M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.56% |
| 2 | Consumer Discretionary | 12.42% |
| 3 | Healthcare | 10.21% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PPLI
576
PUT
People Inc
PPLI
$3.1B
| $30M | 0.04% |
773,285
+91,764
| +13% | +$2.98M |
|
577
PUT
Altria Group
MO
$122B
| $29.9M | 0.04% |
496,300
+79,700
| +19% | +$4.73M |
|
|
HPP
578
Hudson Pacific Properties
HPP
$834M
| $29.9M | 0.04% |
130,337
+44,840
| +52% | +$10.5M |
|
579
Integra LifeSciences
IART
$1.54B
| $29.8M | 0.04% |
453,029
-59,730
| -12% | -$3.71M |
|
|
AGN
580
CALL
DELISTED
Allergan plc
AGN
| $29.8M | 0.04% |
156,300
+64,700
| +71% | +$11.9M |
|
581
PUT
AB InBev
BUD
$158B
| $29.7M | 0.04% |
339,700
+115,000
| +51% | +$11.2M |
|
582
PUT
Nike
NKE
$61.9B
| $29.7M | 0.04% |
350,600
-10,500
| -3% | -$843K |
|
583
Charles River Laboratories
CRL
$10.9B
| $29.7M | 0.04% |
220,394
+63,322
| +40% | +$7.82M |
|
584
CALL
TransDigm Group
TDG
$69.2B
| $29.6M | 0.04% |
79,600
+5,000
| +7% | +$1.8M |
|
585
Boeing
BA
$165B
| $29.4M | 0.04% |
79,143
-148,372
| -65% | -$52.1M |
|
|
PACW
586
DELISTED
PacWest Bancorp
PACW
| $29.4M | 0.04% |
616,961
+64,802
| +12% | +$3.26M |
|
587
Texas Capital Bancshares
TCBI
$4.31B
| $29.3M | 0.04% |
354,539
+147,944
| +72% | +$13.4M |
|
588
PUT
Valero Energy
VLO
$89.8B
| $29.1M | 0.03% |
255,700
+107,000
| +72% | +$12.2M |
|
|
FOLD
589
DELISTED
Amicus Therapeutics
FOLD
| $29M | 0.03% |
2,400,674
-1,324,370
| -36% | -$18.5M |
|
590
Telus
TU
$16B
| $29M | 0.03% |
1,573,000
-391,384
| -20% | -$7.17M |
|
591
Honeywell
HON
$77.1B
| $29M | 0.03% |
192,797
-725,084
| -79% | -$103M |
|
592
Williams-Sonoma
WSM
$26.7B
| $29M | 0.03% |
881,872
-24,116
| -3% | -$765K |
|
593
Marriott Vacations Worldwide
VAC
$3.24B
| $29M | 0.03% |
259,197
+254,335
| +5,231% | +$30.1M |
|
594
Freeport-McMoran
FCX
$90B
| $28.9M | 0.03% |
2,078,971
+1,471,312
| +242% | +$22.2M |
|
|
HES
595
DELISTED
Hess
HES
| $28.9M | 0.03% |
403,807
+157,318
| +64% | +$10.4M |
|
596
Dollar Tree
DLTR
$23.1B
| $28.7M | 0.03% |
352,374
-1,155,027
| -77% | -$101M |
|
597
nVent Electric
NVT
$24.5B
| $28.7M | 0.03% |
1,058,010
-243,842
| -19% | -$6.63M |
|
598
CALL
Domino's
DPZ
$11B
| $28.7M | 0.03% |
97,400
+46,700
| +92% | +$13.2M |
|
599
Neurocrine Biosciences
NBIX
$17.7B
| $28.7M | 0.03% |
233,465
+16,462
| +8% | +$1.87M |
|
600
CALL
Bausch Health
BHC
$1.65B
| $28.6M | 0.03% |
1,115,000
-53,500
| -5% | -$1.23M |
|
Similar funds
D.E. Shaw & Co's Q3 2018 Portfolio in Review
As of Q3 2018, D.E. Shaw & Co held 4,167 positions worth $83.2B, up 8.6% from $76.7B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co's Q3 2018 filing shows 494 new, 1,413 increased, 1,463 reduced and 484 closed positions. Its largest new stake was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M. The largest sale was Apple, an estimated $914M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2018 buy was Six Flags Entertainment Corp.: 850,069 shares worth $59.4M.
- D.E. Shaw & Co added most to AT&T in Q3 2018, an estimated $501M increase.
- D.E. Shaw & Co's biggest Q3 2018 reduction was Apple, cutting an estimated $914M.
- D.E. Shaw & Co fully exited RH in Q3 2018, selling an estimated $43.2M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $83.2B portfolio in Q3 2018.
- D.E. Shaw & Co opened 494 new positions and closed 484 in Q3 2018.
- D.E. Shaw & Co's portfolio value rose 8.6% quarter-over-quarter to $83.2B.
Based on D.E. Shaw & Co's 13F filing for Q3 2018, filed 14 Nov 2018.